Skip to main content
Median Diagnostics Inc. logo

Median Diagnostics Inc. — Investor Relations & Filings

Ticker · 233250 ISIN · KR7233250000 KO Manufacturing
Open in API
Filings indexed 118 across all filing types
Latest filing 2024-12-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 233250

About Median Diagnostics Inc.

https://www.mediandiagnostics.com/en

Median Diagnostics Inc. specializes in the development, manufacturing, and supply of in-vitro diagnostic products for animal diseases. The company provides a comprehensive portfolio of diagnostic solutions, including ELISA and PCR kits, rapid tests, and standard reagents. It also produces essential raw materials such as monoclonal antibodies and antigens. A primary focus is on offering 'Total Diagnostic Systems' for high-consequence animal diseases, including African Swine Fever (ASF), Foot-and-Mouth Disease (FMD), High Pathogenicity Avian Influenza (HPAI), Porcine Epidemic Diarrhea (PED), and Bovine Viral Diarrhea (BVD). The company also supplies raw materials for human disease diagnostic applications.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the acquisition of shares by Nanohelix Co., Ltd. in Median Diagnostics, resulting in a change in their shareholding percentage. This type of filing is a standard regulatory requirement for significant ownership changes (often referred to as a 5% rule filing in other jurisdictions). Since it specifically reports a change in major shareholding levels, it falls under the 'Major Shareholding Notification' category.
2024-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for the purpose of an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of the administrative process for shareholder rights. Given it is a regulatory announcement that does not fit into specific categories like dividend or voting results, it is classified as a general regulatory filing.
2024-12-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Median Diagnostics. It contains the meeting agenda, details on director and auditor appointments, and management reference materials (경영참고사항) including business overviews and market analysis. This type of document is standard for providing shareholders with the necessary information to vote on proposals at a meeting, which falls under the Proxy Solicitation & Information Statement category.
2024-12-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by (주)나노헬릭스 in (주)메디안디노스틱, resulting in a change in shareholding percentage. This type of filing is specifically used to notify the market of significant changes in share ownership (crossing thresholds or changing control), which corresponds to the 'Major Shareholding Notification' category.
2024-12-03 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a short, structured announcement (under 1,000 characters) reporting the results of an Investor Relations (IR) meeting held by Median Diagnostics. It provides details such as the date, time, location, and attendees, and explicitly mentions that the IR materials are posted on the Korea Exchange's disclosure system. Since it is an announcement regarding the occurrence of an event and the availability of materials rather than the presentation itself, it falls under the Report Publication Announcement (RPA) category.
2024-11-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding (specifically a 71.74% stake acquisition by NanoHelix Co., Ltd. in Median Diagnostics) and the purpose of the holding (management influence). This falls under the category of Major Shareholding Notification (MRQ) as it reports a significant change in ownership levels crossing regulatory thresholds.
2024-11-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.